# Safety and Immunogenicity Study of GX-70 in TB Patient

> **NCT03159975** · PHASE1 · WITHDRAWN · sponsor: **Yonsei University**

## Conditions studied

- Pulmonary Tuberculoses
- High Risk Factors for Relapse
- Treatment Failure

## Interventions

- **DRUG:** GX-70 by electroporation
- **DRUG:** GX-70 by electroporation
- **DRUG:** GX-70 by electroporation

## Key facts

- **NCT ID:** NCT03159975
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-03
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unconfirmed research expenses
- **Last updated:** 2019-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03159975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03159975, "Safety and Immunogenicity Study of GX-70 in TB Patient". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03159975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*